Philips announces its 2016 First Quarter results
Philips launches COPD insider, a new online hub for key opinion leaders in COPD care
Oct 25, 2016 - In conjunction with Respiratory Care Week (October 23 – 29), Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of COPD insider, an online community where leaders in value-based Chronic Obstructive Pulmonary Disease (COPD) care will discuss new and innovative solutions, highlight the biggest issues in COPD care, share a wealth of knowledge and provide practical solutions for COPD care professionals.
Multi-Center Clinical Validation Study by Philips to be Submitted to FDA in Support of Expanded Indications for Use for Philips IntelliSite Digital Pathology Solution in the U.S.
Oct 21, 2016 - Royal Philips (NYSE: PHG, AEX: PHIA) today announced the successful completion of its well-controlled, multicenter pivotal validation study designed to compare diagnoses determined by pathologists from digital whole slide imaging to traditional optical diagnoses through a microscope.
FluoroPharma and Philips collaborate on image management for CardioPET Phase II clinical trial
Oct 18, 2016 - Royal Philips (NSYE: PHG, AEX: PHIA) announced today that it has been collaborating with FluoroPharma Medical Inc (OTCQB: FPMI) for data management in conjunction with its Phase II clinical trials for its lead agent CardioPET (18-F FCPHA). Safety and image data from the CardioPET study was presented at the European Association of Nuclear Medicine Annual (EANM) Congress in Barcelona, Spain, on October 16th.
Philips receives FDA 510(k) clearance for Lumify’s S4-1 transducer bringing new capabilities, including cardiac imaging, to this smart-device ultrasound
Oct 14, 2016 - – Royal Philips (NYSE: PHG AEX: PHIA) today announced at The American College of Emergency Physicians’ (ACEP) annual meeting that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its innovative S4-1 cardiac transducer for Lumify, its smart-device diagnostic ultrasound solution.
Philips to offer integrated Image Guided Therapy solutions in Canada
Oct 04, 2016 - Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has incorporated its Volcano catheter-based imaging and measurement solutions for minimally invasive diagnostics and treatment of cardiovascular and other disease, into its robust portfolio of interventional cardiology solutions in Canada.
Philips unveils next-generation of IntelliVue Guardian software to aid clinicians in identifying potential signs of early deteriorations
Oct 04, 2016 - Royal Philips (NYSE: PHG, AEX: PHIA), today announced the latest version of the IntelliVue Guardian software, designed to aid clinicians in the early recognition of subtle signs of patient deterioration in the general care ward.
All press releases
Global News Center
Annual report 2015
Keep up with our News Alerts, automatically delivered to your inbox